What is the
CaReMe Global Alliance
CaReMe is a patient-centric initiative to enable early diagnosis and interdisciplinary integrated care of people living in the CaReMe risk continuum to improve health outcomes.
Is CaReMe
right for you?
Did you know that an integrated, interdisciplinary approach to cardiovascular, renal and metabolic treatment improves clinical outcomes, increases cost effectiveness and enhances resource utilisation?
Real World Evidence global registry
Analyse and benchmark your data using an established global registry.
Interdisciplinary virtual clinic
Connect patients, healthcare professionals and payors on a single platform.
Integrated risk score and prediction
Prevent future health complications and drive positive behavioural change.
CaReMe news
Read our latest news from the organisation or general medical news. Feel free to ask questions in the comments about any news you find interesting.
8. February 2021
In November 2020, a review published in the journal Cardiovascular Diabetology highlighted the renoprotective benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type-2 diabetes patients, over a spectrum of cardiovascular and renal risk profiles.
Copyright by CaReMe Global Alliance 2022. All rights reserved.